Table 2.
Classification and outcome of epilepsy in the study cohorts.
| TUBA1A | TUBB2B | P Value | |
|---|---|---|---|
| Classification of epilepsy | |||
| Focal |
13/40 32.5% |
3/11 27.3% |
1.0 |
| Generalized |
12/40 30.0% |
6/11 54.5% |
0.165 |
| Infantile spasms |
13/40 32.5% |
3/11 27.3% |
1.0 |
| Specific semiologies | |||
| Absence |
2/40 5.0% |
0/11 0.0% |
1.0 |
| Tonic |
4/40 10.0% |
2/11 18.2% |
0.598 |
| Clonic |
2/40 5.0% |
0/11 0.0% |
1.0 |
| Tonic–clonic |
8/40 20.0% |
2/11 18.2% |
1.0 |
| Myoclonic |
5/40 12.5% |
0/11 0.0% |
0.572 |
| Other |
4/40 10.0% |
2/11 18.2% |
0.598 |
| Epilepsy outcome |
54/82 65.9% |
17/31 54.8% |
0.286 |
| Intractable/refractory seizures |
22/34 64.7% |
3/8 37.5% |
0.235 |
| Occasional/controlled seizures |
12/34 35.3% |
5/8 62.5% |
0.235 |
| Not assessed |
20/54 37.0% |
9/17 52.9% |
– |
Prevalence and course of epilepsy, seizures types, and outcome are listed. Proportions are illustrated in numbers (top) and percentages (bottom).